王曉煥,尹昭,劉婷,李先花
?
芪藶強(qiáng)心膠囊對冠心病患者心臟舒張功能的影響
王曉煥,尹昭,劉婷,李先花
[摘要]目的:探討芪藶強(qiáng)心膠囊對冠心病患者心臟舒張功能的影響。方法:選擇“IL-33和eNOS基因標(biāo)簽SNPs與冠心病發(fā)生的關(guān)聯(lián)研究”中經(jīng)冠脈造影明確診斷為冠心病,左心功能正常而存在左室舒張功能異常、未行冠脈介入治療的患者89例,其中43例患者在冠心病二級預(yù)防治療基礎(chǔ)上加用芪藶強(qiáng)心膠囊治療作為治療組,46例患者僅給予冠心病二級預(yù)防作為對照組,觀察12周,采用多普勒超聲心動圖檢測冠心病患者治療前后左室收縮功能指標(biāo)射血分?jǐn)?shù)(LVEF),左室舒張功能指標(biāo)E波峰值速度(E),A波峰值速度(A),E峰與A峰速度比值(E/A),對2組患者治療前后上述指標(biāo)變化進(jìn)行統(tǒng)計(jì)學(xué)分析。結(jié)果:2組患者治療后左室收縮功能指標(biāo)及舒張功能指標(biāo)較治療前相比較均有改善,差異有統(tǒng)計(jì)學(xué)意義(P<0.05);治療組左室收縮功能指標(biāo)及舒張功能指標(biāo)較對照組改善較好,差異有統(tǒng)計(jì)學(xué)意義(P<0.05)。結(jié)論:芪藶強(qiáng)心膠囊對冠心病患者左室舒張功能有改善作用。
[關(guān)鍵詞]冠狀動脈疾病;舒張功能;芪藶強(qiáng)心膠囊
Effect of qiliqiangxin capsule on left ventricular diastolic function in patients with coronary heart diseaseWANGXiao-huan,YINZhao,LIUTing,etal.(TheFourthAffiliatedHospitalofKunmingMedicalUniversity,Yunnan650021,China)
【Abstract】Objective:To evaluate the effect of qiliqiangxin capsule on left ventricular diastolic function in patients with coronary heart disease.Methods:89 cases of patients with coronary heart disease accompanied by ventricular diastolic dysfunction were randomly divided into two groups, a treatment group (n=43) and a control group (n=46). The control group was just given grade 2 prevention treatment, and the treatment group, on the basis of the control group treatment, was added with qiliqiangxin capsule 1.2g,3 times per day for 12 weeks.Results:After treatment, the left ventricular diastolic function indicator (E/A ratio) and left ventricular systolic function indicator (LVEF) of the two groups significantly improved(P<0.05).The left ventricular diastolic function indicator (E/A ratio) and left ventricular systolic function indicator (LVEF) of the treatment group improved better compared with the control group(P<0.05).Conclusion:Grade 2 prevention and treatment of coronary heart disease combined with qiliqiangxin capsule can improve left ventricular diastolic function and left ventricular systolic function in patients with coronary heart disease.
【Key words】Coronary artery disease; Diastolic function; Qiliqiangxin capsule
研究[1]表明,冠心病患者尤其在心肌缺血發(fā)作時,心臟收縮和舒張功能均發(fā)生異常,而舒張功能障礙可發(fā)生在癥狀和心電改變之前。心臟舒張功能異常是冠心病心功能受累早期改變的敏感指標(biāo),91%的冠心病患者存在左室舒張功能障礙[2]。舒張功能異常的患者反復(fù)入院率較高,影響患者生活質(zhì)量,本研究對芪藶強(qiáng)心膠囊對冠心病患者舒張功能的影響進(jìn)行探討,旨在為改善冠心病患者舒張功能不全患者選擇有效的藥物提供依據(jù)。……